Acharya, C., Jayasinghe, R., D'Souza, D., Hamilton, M., Foltz, S., Chen, Z., Kim-Schulze, S., Cho, H., Kumar, S., Mulligan, G. (2025). Daratumumab-based quadruplet therapy in functional high-risk relapse/refractory multiple myeloma patients induces changes associated with CD8 T cell signaling, activation and expansion. Blood. https://doi.org/10.1182/blood-2025-3955